A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension

The purpose of this study is to evaluate the intraocular pressure(IOP)-lowering efficacy of a combination IOP-lowering therapy in patients with open-angle glaucoma or ocular hypertension.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma, Open-Angle Eye Diseases Glaucoma Ocular Hypertension

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

European Facilitiies

Puurs, Belgium

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

As specified in protocol

Exclusion criteria

As specified in protocol

Treatment and study plan

Travoprost 0.004%/Timolol maleate 0.5% ophthalmic solution

Drug

Investigational ophthalmic solution intended for the treatment of open-angle glaucoma or ocular hypertension

Latanoprost 0.005%/Timolol 0.005% ophthalmic solution

Drug

Commercially marketed ophthalmic solution intended for the treatment of open-angle glaucoma or ocular hypertension

Primary outcomes

Mean Intraocular Pressure (IOP)

Time frame: 12 months

Sponsors and collaborators

Lead sponsor

Alcon Research

Industry

Registry information

Important dates

Study start: 2003
Primary completion: 2004
Study completion: 2004
First posted: Apr 6, 2006
Registry last updated: Feb 14, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed